drugset / Trial / NCT00401687

DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function

NCT00401687

Phase 4 Completed 131 enrolled Lantheus Medical Imaging
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).

Timeline

Start
2006-07
Primary completion
2007-06
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Definity Diagnostic / imaging agent

Indications

No indication recorded.